Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
華爾街最準確的分析師聚焦於3只醫療保健股票，提供高股息收益。
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市場動盪和不確定性時期，許多投資者都會轉向具有股息收益的股票。這些往往是擁有高自由現金流並向股東支付高股息的公司。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的讀者可以查看我們的分析師股票評級頁面，查看最新的分析師對他們最喜愛的股票的看法。交易員可以瀏覽Benzinga的廣泛分析師評級數據庫，包括按分析師準確性排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是醫療保健板塊三隻高收益股票最準確的分析師評級。
Pfizer Inc. (NYSE:PFE)
輝瑞公司(NYSE:PFE)
- Dividend Yield: 5.88%
- Barclays analyst Carter Gould maintained an Equal-Weight rating and raised the price target from $30 to $32 on July 31. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and boosted the price target from $28 to $30 on July 31. This analyst has an accuracy rate of 78%.
- Recent News: On Monday, Pfizer released top-line safety and immunogenicity results from substudy B of the ongoing pivotal MONeT Phase 3 trial,evaluating two doses of Abrysvo vaccine in immunocompromised adults aged 18 and older at risk of developing severe respiratory syncytial virus-associated lower respiratory tract disease.
- Benzinga Pro's real-time newsfeed alerted to latest PFE news
- 股息收益率：5.88%
- 巴克萊銀行分析師Carter Gould於7月31日維持Equal-Weight評級，將價格目標從30美元上調至32美元。該分析師的準確率爲60%。
- 威爾斯·法戈分析師Mohit Bansal於7月31日維持Equal-Weight評級，將價格目標從28美元上調至30美元。該分析師的準確率爲78%。
- 最近新聞：輝瑞公司在進行重大MONet 3期臨床試驗的子研究b中發佈了Abrysvo疫苗兩種劑量在18歲及以上的免疫功能低下的成年人中評估嚴重呼吸合胞病毒相關的下呼吸道疾病的安全性和免疫原性結果的首要安全性和免疫原性結果。
- Benzinga Pro的實時新聞提醒了最新的PFE新聞
GSK plc (NYSE:GSK)
GSK股票（NYSE：GSK）
- Dividend Yield: 3.80%
- Jefferies analyst Peter Welford maintained a Buy rating and raised the price target from $52.5 to $53 on July 2. This analyst has an accuracy rate of 70%.
- Guggenheim analyst Seamus Fernandez upgraded the stock from Neutral to Buy on March 4. This analyst has an accuracy rate of 62%.
- Recent News: On July 31, GSK reported second-quarter sales of $9.95 billion (7.88 billion Sterling Pounds), up 10% year-over-year and 13% on constant currency..
- Benzinga Pro's charting tool helped identify the trend in GSK stock.
- 股息收益率：3.80%
- 傑富瑞證券分析師Peter Welford於7月2日維持買入評級，將價格目標從52.5美元上調至53美元。該分析師的準確率爲70%。
- 古根海姆分析師Seamus Fernandez於3月4日將該股票的評級由中立上調至買入。該分析師的準確率爲62%。
- 最近的新聞：7月31日，GSK報告第二季度銷售額爲99.5億美元（78.8億英鎊），同比增長10％，按恒定匯率計算增長13％。
- Benzinga Pro的製圖工具有助於識別出GSK股票的趨勢。
CVS Health Corporation (NYSE:CVS)
西維斯健康公司（紐約證券交易所股票代碼：CVS）
- Dividend Yield: 4.66%
- Deutsche Bank analyst George Hillmaintained a Hold rating and cut the price target from $64 to $63 on Aug. 9. This analyst has an accuracy rate of 60%.
- Barclays analyst Andrew Mok maintained an Equal-Weight rating and slashed the price target from $65 to $63 on Aug. 8. This analyst has an accuracy rate of 66%.
- Recent News: On Aug. 7, CVS Health reported mixed second-quarter earnings and cut annual profit guidance.
- Benzinga Pro's signals feature notified of a potential breakout in CVS shares.
- 股息收益率：4.66%
- 德意志銀行分析師George Hill於8月9日維持持有評級，將價格目標從64美元下調至63美元。該分析師的準確率爲60%。
- 巴克萊銀行分析師Andrew Mok於8月8日維持Equal-Weight評級，將價格目標從65美元下調至63美元。該分析師的準確率爲66%。
- 最近新聞：8月7日，西維斯健康報告了二季度收益不佳，並下調了年度利潤指引。
- Benzinga Pro的信號特徵指出CVS股票的潛在突破。
Read More:
閱讀更多：
- Dow Settles Higher But Records Weekly Loss: Greed Index Remains In 'Extreme Fear' Zone
- 道瓊斯收漲，但本週下跌：貪婪指數仍處於「極度恐懼」區域。
資訊熱榜
更新時間